tradingkey.logo
搜索

Integra Lifesciences Holdings Corp

IART
添加自选
18.050USD
+0.160+0.89%
收盘 07/02, 13:00美东报价延迟15分钟
1.41B总市值
亏损市盈率 TTM

Integra Lifesciences Holdings Corp

18.050
+0.160+0.89%

关于 Integra Lifesciences Holdings Corp 公司

Integra LifeSciences Holdings Corporation is a global medical technology company. The Company manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). The CSS segment consists of technologies and instrumentation used for a range of specialties, such as neurosurgery, neurocritical care and otolaryngology. The CSS business consists of a portfolio of brands, such as Codman, DuraGen, DuraSeal, CUSA, Mayfield, Bactiseal, and Certas Plus, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. It provides instruments that are used in precision, specialty and general surgical procedures. The TT segment is focused on three main areas: complex wound surgery, surgical reconstruction and peripheral nerve repair. The TT segment offers skin and wound repair, plastics and surgical reconstruction products, and others.

Integra Lifesciences Holdings Corp简介

公司代码IART
公司名称Integra Lifesciences Holdings Corp
上市日期Aug 16, 1995
CEOPoul (Mojdeh)
员工数量4396
证券类型Ordinary Share
年结日Aug 16
公司地址1100 Campus Road
城市PRINCETON
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编08540
电话16092750500
网址https://www.integralife.com/
公司代码IART
上市日期Aug 16, 1995
CEOPoul (Mojdeh)

Integra Lifesciences Holdings Corp公司高管

名称
名称/职务
职务
持股
持股变动
Ms. Mojdeh Poul
Ms. Mojdeh Poul
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
102.30K
--
Mr. Christian S. (Chris) Schade
Mr. Christian S. (Chris) Schade
Independent Director
Independent Director
90.03K
--
Dr. Keith Bradley, Ph.D.
Dr. Keith Bradley, Ph.D.
Independent Director
Independent Director
88.25K
-1.00%
Ms. Lea Daniels Knight
Ms. Lea Daniels Knight
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
50.49K
-16.02%
Mr. Harvinder Singh
Mr. Harvinder Singh
Executive Vice President, President - International Business
Executive Vice President, President - International Business
35.42K
+38.07%
Mr. Jeffrey Mosebrook
Mr. Jeffrey Mosebrook
Senior Vice President - Finance, Principal Accounting Officer
Senior Vice President - Finance, Principal Accounting Officer
34.65K
-3.31%
Dr. Stuart M. Essig, Ph.D.
Dr. Stuart M. Essig, Ph.D.
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Mr. Robert T. Davis, Jr.
Mr. Robert T. Davis, Jr.
Executive Vice President, President - Tissue Technologies
Executive Vice President, President - Tissue Technologies
--
--
Ms. Barbara B. Hill
Ms. Barbara B. Hill
Independent Presiding Director
Independent Presiding Director
--
--
Mr. Eric I. Schwartz
Mr. Eric I. Schwartz
Executive Vice President, Chief Legal Officer, Secretary
Executive Vice President, Chief Legal Officer, Secretary
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Ms. Mojdeh Poul
Ms. Mojdeh Poul
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
102.30K
--
Mr. Christian S. (Chris) Schade
Mr. Christian S. (Chris) Schade
Independent Director
Independent Director
90.03K
--
Dr. Keith Bradley, Ph.D.
Dr. Keith Bradley, Ph.D.
Independent Director
Independent Director
88.25K
-1.00%
Ms. Lea Daniels Knight
Ms. Lea Daniels Knight
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
50.49K
-16.02%
Mr. Harvinder Singh
Mr. Harvinder Singh
Executive Vice President, President - International Business
Executive Vice President, President - International Business
35.42K
+38.07%
Mr. Jeffrey Mosebrook
Mr. Jeffrey Mosebrook
Senior Vice President - Finance, Principal Accounting Officer
Senior Vice President - Finance, Principal Accounting Officer
34.65K
-3.31%

常见问题

Integra Lifesciences Holdings Corp的前五大股东是谁?

Integra Lifesciences Holdings Corp 的前五大股东如下:Ms. Mojdeh Poul

有多少机构持有Integra Lifesciences Holdings Corp(IART)的股份?

截至2026Q1,共有574家机构持有Integra Lifesciences Holdings Corp的股份,合计持有的股份价值约为82.80M,占公司总股份的106.43%。与2025Q4相比,机构持股有所增加,增幅为-14508057.00。

哪个业务部门对Integra Lifesciences Holdings Corp的收入贡献最大?

在2026Q1,Neurosurgery业务部门对Integra Lifesciences Holdings Corp的收入贡献最大,创收827.67M,占总收入的50.61%。